ID

25848

Descrizione

Safety Study of Tecadenoson to Treat Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT00713401

collegamento

https://clinicaltrials.gov/show/NCT00713401

Keywords

versioni (1)
  1. 21/09/17 21/09/17 -
Caricato su

21 settembre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Atrial Fibrillation NCT00713401

Inglese

Eligibility Atrial Fibrillation NCT00713401

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
have a diagnosis of atrial fibrillation in need of treatment for rate control
Descrizione

Atrial Fibrillation | Treatment required for rate control

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2,1]
C0332121
UMLS CUI [2,2]
C0489879
be able and willing to abstain from any antiarrhythmics, including atrioventricular (av) nodal blocking agents (except for esmolol per protocol), from no later than 8:00 p.m. on the day prior to dosing until completion of the last dose period assessment
Descrizione

Abstinence Anti-Arrhythmia Agents | Abstinence Pharmaceutical Preparations AV node Blocking | Exception Esmolol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3843422
UMLS CUI [1,2]
C0003195
UMLS CUI [2,1]
C3843422
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0004247
UMLS CUI [2,4]
C0332206
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0116569
be able and willing to abstain from xanthine- or chocolate-containing foods, beverages, and medications
Descrizione

Abstinence Food Containing Xanthine | Abstinence Food Containing Chocolate | Abstinence Beverages Containing Xanthine | Abstinence Beverages Containing Chocolate | Abstinence Pharmaceutical Preparations Containing Xanthine | Abstinence Pharmaceutical Preparations Containing Chocolate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3843422
UMLS CUI [1,2]
C0016452
UMLS CUI [1,3]
C0332256
UMLS CUI [1,4]
C0043314
UMLS CUI [2,1]
C3843422
UMLS CUI [2,2]
C0016452
UMLS CUI [2,3]
C0332256
UMLS CUI [2,4]
C0008299
UMLS CUI [3,1]
C3843422
UMLS CUI [3,2]
C0005329
UMLS CUI [3,3]
C0332256
UMLS CUI [3,4]
C0043314
UMLS CUI [4,1]
C3843422
UMLS CUI [4,2]
C0005329
UMLS CUI [4,3]
C0332256
UMLS CUI [4,4]
C0008299
UMLS CUI [5,1]
C3843422
UMLS CUI [5,2]
C0013227
UMLS CUI [5,3]
C0332256
UMLS CUI [5,4]
C0043314
UMLS CUI [6,1]
C3843422
UMLS CUI [6,2]
C0013227
UMLS CUI [6,3]
C0332256
UMLS CUI [6,4]
C0008299
females must be post-menopausal or sterilized; or if of childbearing potential, must not be breastfeeding and must have a negative pregnancy test at screening and no intention of becoming pregnant during the course of the study. males and females must be using adequate contraception during the study.
Descrizione

Postmenopausal state | Female Sterilization | Childbearing Potential Breast Feeding Absent | Childbearing Potential Pregnancy test negative | Childbearing Potential Planned Pregnancy Absent | Contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C0015787
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0006147
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0427780
UMLS CUI [5,1]
C3831118
UMLS CUI [5,2]
C0032992
UMLS CUI [5,3]
C0332197
UMLS CUI [6]
C0700589
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
have a known accessory pathway
Descrizione

Accessory cardiac pathway

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1963785
have active myocardial ischemia or recent acute coronary syndrome
Descrizione

Myocardial Ischemia | Acute Coronary Syndrome

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151744
UMLS CUI [2]
C0948089
have acute or overt heart failure, bradycardia, heart block greater than first degree, or cardiogenic shock
Descrizione

Heart failure | Bradycardia | Second degree atrioventricular block | Complete atrioventricular block | Shock, Cardiogenic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2]
C0428977
UMLS CUI [3]
C0264906
UMLS CUI [4]
C0151517
UMLS CUI [5]
C0036980
have allergies or contraindications to treatment with esmolol or aminophylline, or any of their constituents
Descrizione

Esmolol allergy | Aminophylline allergy | Hypersensitivity Esmolol Constituents | Hypersensitivity Aminophylline Constituents | Medical contraindication Esmolol | Medical contraindication Aminophylline | Medical contraindication Esmolol Constituents | Medical contraindication Aminophylline Constituents

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0570888
UMLS CUI [2]
C0571074
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0116569
UMLS CUI [3,3]
C0729650
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0002575
UMLS CUI [4,3]
C0729650
UMLS CUI [5,1]
C1301624
UMLS CUI [5,2]
C0116569
UMLS CUI [6,1]
C1301624
UMLS CUI [6,2]
C0002575
UMLS CUI [7,1]
C1301624
UMLS CUI [7,2]
C0116569
UMLS CUI [7,3]
C0729650
UMLS CUI [8,1]
C1301624
UMLS CUI [8,2]
C0002575
UMLS CUI [8,3]
C0729650
have a supine cuff systolic blood pressure < 90 mm hg
Descrizione

Lying systolic blood pressure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1319895
be undergoing treatment with theophylline/aminophylline preparations, trental®
Descrizione

Theophylline | Aminophylline | Trental

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0039771
UMLS CUI [2]
C0002575
UMLS CUI [3]
C0699487
(pentoxifylline), or carbamazepine
Descrizione

Pentoxifylline | Carbamazepine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0030899
UMLS CUI [2]
C0006949
have asthma or other reactive airways disease currently on-treatment
Descrizione

Therapeutic procedure Asthma | Therapeutic procedure Reactive airway disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0004096
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C3714497
have a history of an active or chronic pancreatic disease or clinically significant increased levels of serum amylase or lipase
Descrizione

Pancreatic Disease | Pancreatic Disease chronic | Serum amylase raised | Serum lipase raised

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0030286
UMLS CUI [2,1]
C0030286
UMLS CUI [2,2]
C0205191
UMLS CUI [3]
C0476327
UMLS CUI [4]
C3670924
Ritorna all'inizio della pagina

Similar models

Eligibility Atrial Fibrillation NCT00713401

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Atrial Fibrillation | Treatment required for rate control
Item
have a diagnosis of atrial fibrillation in need of treatment for rate control
boolean
C0004238 (UMLS CUI [1])
C0332121 (UMLS CUI [2,1])
C0489879 (UMLS CUI [2,2])
Abstinence Anti-Arrhythmia Agents | Abstinence Pharmaceutical Preparations AV node Blocking | Exception Esmolol
Item
be able and willing to abstain from any antiarrhythmics, including atrioventricular (av) nodal blocking agents (except for esmolol per protocol), from no later than 8:00 p.m. on the day prior to dosing until completion of the last dose period assessment
boolean
C3843422 (UMLS CUI [1,1])
C0003195 (UMLS CUI [1,2])
C3843422 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0004247 (UMLS CUI [2,3])
C0332206 (UMLS CUI [2,4])
C1705847 (UMLS CUI [3,1])
C0116569 (UMLS CUI [3,2])
Abstinence Food Containing Xanthine | Abstinence Food Containing Chocolate | Abstinence Beverages Containing Xanthine | Abstinence Beverages Containing Chocolate | Abstinence Pharmaceutical Preparations Containing Xanthine | Abstinence Pharmaceutical Preparations Containing Chocolate
Item
be able and willing to abstain from xanthine- or chocolate-containing foods, beverages, and medications
boolean
C3843422 (UMLS CUI [1,1])
C0016452 (UMLS CUI [1,2])
C0332256 (UMLS CUI [1,3])
C0043314 (UMLS CUI [1,4])
C3843422 (UMLS CUI [2,1])
C0016452 (UMLS CUI [2,2])
C0332256 (UMLS CUI [2,3])
C0008299 (UMLS CUI [2,4])
C3843422 (UMLS CUI [3,1])
C0005329 (UMLS CUI [3,2])
C0332256 (UMLS CUI [3,3])
C0043314 (UMLS CUI [3,4])
C3843422 (UMLS CUI [4,1])
C0005329 (UMLS CUI [4,2])
C0332256 (UMLS CUI [4,3])
C0008299 (UMLS CUI [4,4])
C3843422 (UMLS CUI [5,1])
C0013227 (UMLS CUI [5,2])
C0332256 (UMLS CUI [5,3])
C0043314 (UMLS CUI [5,4])
C3843422 (UMLS CUI [6,1])
C0013227 (UMLS CUI [6,2])
C0332256 (UMLS CUI [6,3])
C0008299 (UMLS CUI [6,4])
Postmenopausal state | Female Sterilization | Childbearing Potential Breast Feeding Absent | Childbearing Potential Pregnancy test negative | Childbearing Potential Planned Pregnancy Absent | Contraceptive methods
Item
females must be post-menopausal or sterilized; or if of childbearing potential, must not be breastfeeding and must have a negative pregnancy test at screening and no intention of becoming pregnant during the course of the study. males and females must be using adequate contraception during the study.
boolean
C0232970 (UMLS CUI [1])
C0015787 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0006147 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C3831118 (UMLS CUI [4,1])
C0427780 (UMLS CUI [4,2])
C3831118 (UMLS CUI [5,1])
C0032992 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
C0700589 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
Accessory cardiac pathway
Item
have a known accessory pathway
boolean
C1963785 (UMLS CUI [1])
Myocardial Ischemia | Acute Coronary Syndrome
Item
have active myocardial ischemia or recent acute coronary syndrome
boolean
C0151744 (UMLS CUI [1])
C0948089 (UMLS CUI [2])
Heart failure | Bradycardia | Second degree atrioventricular block | Complete atrioventricular block | Shock, Cardiogenic
Item
have acute or overt heart failure, bradycardia, heart block greater than first degree, or cardiogenic shock
boolean
C0018801 (UMLS CUI [1])
C0428977 (UMLS CUI [2])
C0264906 (UMLS CUI [3])
C0151517 (UMLS CUI [4])
C0036980 (UMLS CUI [5])
Esmolol allergy | Aminophylline allergy | Hypersensitivity Esmolol Constituents | Hypersensitivity Aminophylline Constituents | Medical contraindication Esmolol | Medical contraindication Aminophylline | Medical contraindication Esmolol Constituents | Medical contraindication Aminophylline Constituents
Item
have allergies or contraindications to treatment with esmolol or aminophylline, or any of their constituents
boolean
C0570888 (UMLS CUI [1])
C0571074 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0116569 (UMLS CUI [3,2])
C0729650 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0002575 (UMLS CUI [4,2])
C0729650 (UMLS CUI [4,3])
C1301624 (UMLS CUI [5,1])
C0116569 (UMLS CUI [5,2])
C1301624 (UMLS CUI [6,1])
C0002575 (UMLS CUI [6,2])
C1301624 (UMLS CUI [7,1])
C0116569 (UMLS CUI [7,2])
C0729650 (UMLS CUI [7,3])
C1301624 (UMLS CUI [8,1])
C0002575 (UMLS CUI [8,2])
C0729650 (UMLS CUI [8,3])
Lying systolic blood pressure
Item
have a supine cuff systolic blood pressure < 90 mm hg
boolean
C1319895 (UMLS CUI [1])
Theophylline | Aminophylline | Trental
Item
be undergoing treatment with theophylline/aminophylline preparations, trental®
boolean
C0039771 (UMLS CUI [1])
C0002575 (UMLS CUI [2])
C0699487 (UMLS CUI [3])
Pentoxifylline | Carbamazepine
Item
(pentoxifylline), or carbamazepine
boolean
C0030899 (UMLS CUI [1])
C0006949 (UMLS CUI [2])
Therapeutic procedure Asthma | Therapeutic procedure Reactive airway disease
Item
have asthma or other reactive airways disease currently on-treatment
boolean
C0087111 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C3714497 (UMLS CUI [2,2])
Pancreatic Disease | Pancreatic Disease chronic | Serum amylase raised | Serum lipase raised
Item
have a history of an active or chronic pancreatic disease or clinically significant increased levels of serum amylase or lipase
boolean
C0030286 (UMLS CUI [1])
C0030286 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0476327 (UMLS CUI [3])
C3670924 (UMLS CUI [4])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial